Key result
Ischemic heart disease underlies most ventricular mural thrombi despite clinical detection in only ~3%.
Why the study?
Ventricular mural thrombi are rare and often clinically undetected, with unclear etiopathogenesis across ischemic, nonischemic, and non-cardiac causes.
Observational (n=93)
Ventricular mural thrombi are frequently underdiagnosed clinically and can occur in patients without primary cardiac disorders, highlighting the need to rule them out in cases of systemic or pulmonary thromboembolism.
Ventricular mural thrombi appear underdiagnosed in this autopsy cohort; leaves open whether targeted imaging improves thromboembolism outcomes.
Background: Ventricular mural thrombi are rare occurrences and form one of the common mechanical complications of myocardial infarctions. They also occur in patients with nonischemic myocardial disorders and even in those devoid of cardiac diseases. Clinical detection often depends on the size of the thrombi. Aim: This study was aimed at ascertaining the etiopathogenesis of mural thrombi with a clinicopathologic correlation. Materials and Methods: This was a 12-year retrospective observational study reviewing the autopsy records of all cases showing ventricular mural thrombi. The location, size, morphology, and histologic appearances of the thrombi were noted. The cases, depending on the etiology, were categorized into myocardial ischemic (Group 1), myocardial nonischemic (Group 2), and non-myocardial (Group 3) causes. These features were correlated with the clinical settings. Results: There were 93 cases of mural thrombi with an almost equal sex distribution and a mean age of 45.9 years. The cause was ischemic heart disease in most of the patients (Group 1, 46.2%), while 21.5% and 32.3% of patients belonged to Group 2 and Group 3, respectively. Unlike the large and dominantly left ventricular thrombi seen in Group 1, the other two groups frequently had biventricular involvement, location in the intertrabecular spaces, and a high microscopic detection. Clinical diagnosis had been made in only 3.2% of patients. Thromboembolism was noted in other organs in 34.4% of the total cases. Conclusion: Ventricular thrombi should be ruled out in patients with evidence of systemic and/or pulmonary thromboembolism, even in those without any cardiac disorders.
No takes yet. Share an insight, caveat, or question.
Vaideeswar et al. (2024) conducted an observational in Ventricular mural thrombi (n=93). Ischemic heart disease, nonischemic myocardial disorders, and non-myocardial causes was evaluated on Etiopathogenesis and clinicopathologic features of mural thrombi. Ischemic heart disease was the most common cause of ventricular mural thrombi (46.2% of 93 autopsy cases), while clinical diagnosis was made in only 3.2% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: